NEWS & UPDATES
InSitu Technologies Advances Pakistan Market Entry with Distributor License Filing
InSitu Technologies (Pvt) Limited has formally submitted its application for a Form 8C New Distributor Drug Sale License (DSL) to the Directorate of Drugs Control, Punjab, marking a key regulatory milestone in the company's Pakistan market entry strategy.
The application, filed on August 3, 2026, designates the company's premises at Plot #11, Street S-2, RCCI Industrial Estate, Rawat, as the licensed distribution point. This filing supports InSitu's import-and-distribution strategy, an early-revenue pathway running in parallel with the company's planned domestic stent manufacturing facility, while the DRAP manufacturing license and downstream Free Sale Certificate process move forward.
Securing the DSL is a foundational step that will enable InSitu to legally distribute its cardiovascular and peripheral stent portfolio in the Punjab market ahead of full domestic production coming online.
The application, filed on August 3, 2026, designates the company's premises at Plot #11, Street S-2, RCCI Industrial Estate, Rawat, as the licensed distribution point. This filing supports InSitu's import-and-distribution strategy, an early-revenue pathway running in parallel with the company's planned domestic stent manufacturing facility, while the DRAP manufacturing license and downstream Free Sale Certificate process move forward.
Securing the DSL is a foundational step that will enable InSitu to legally distribute its cardiovascular and peripheral stent portfolio in the Punjab market ahead of full domestic production coming online.